Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 153 entries
Sorted by: Best Match Show Resources per page
Antidiabetic effect of enterolactone in cultured muscle cells and in type 2 diabetic model db/db mice.

Cytotechnology

Zhou F, Furuhashi K, Son MJ, Toyozaki M, Yoshizawa F, Miura Y, Yagasaki K.
PMID: 27000262
Cytotechnology. 2017 Jun;69(3):493-502. doi: 10.1007/s10616-016-9965-2. Epub 2016 Mar 21.

Enterolactone (ENL) is formed by the conversion of dietary precursors like strawberry lignans via the gut microbiota. Urinary concentrations of lignan metabolites are reported to be significantly associated with a lower risk of Type 2 diabetes (T2D). In the...

Cite
Zhou F, Furuhashi K, Son MJ, et al. Antidiabetic effect of enterolactone in cultured muscle cells and in type 2 diabetic model db/db mice. Cytotechnology. 2016;69(3):493-502doi: 10.1007/s10616-016-9965-2.
Zhou, F., Furuhashi, K., Son, M. J., Toyozaki, M., Yoshizawa, F., Miura, Y., & Yagasaki, K. (2017). Antidiabetic effect of enterolactone in cultured muscle cells and in type 2 diabetic model db/db mice. Cytotechnology, 69(3), 493-502. https://doi.org/10.1007/s10616-016-9965-2
Zhou, Fang, et al. "Antidiabetic effect of enterolactone in cultured muscle cells and in type 2 diabetic model db/db mice." Cytotechnology vol. 69,3 (2017): 493-502. doi: https://doi.org/10.1007/s10616-016-9965-2
Zhou F, Furuhashi K, Son MJ, Toyozaki M, Yoshizawa F, Miura Y, Yagasaki K. Antidiabetic effect of enterolactone in cultured muscle cells and in type 2 diabetic model db/db mice. Cytotechnology. 2017 Jun;69(3):493-502. doi: 10.1007/s10616-016-9965-2. Epub 2016 Mar 21. PMID: 27000262; PMCID: PMC5461240.
Copy Download .nbib Format: NLM
A case of treatment with voriconazole for chronic progressive pulmonary aspergillosis in a patient receiving tacrolimus for dermatomyositis-associated interstitial lung disease.

Respiratory medicine case reports

Mochizuki E, Furuhashi K, Fujisawa T, Enomoto N, Inui N, Nakamura Y, Kono M, Hamada E, Maekawa M, Suda T.
PMID: 26744690
Respir Med Case Rep. 2015 Nov 03;16:163-5. doi: 10.1016/j.rmcr.2015.10.008. eCollection 2015.

We report a successful treatment with voriconazole (VRCZ) for chronic progressive pulmonary aspergillosis (CPPA) in a patient with dermatomyositis-associated interstitial lung disease (DM-ILD) treated with tacrolimus. A 73-year-old man with DM-ILD, treated with tacrolimus and prednisolone, complained of productive...

Cite
Mochizuki E, Furuhashi K, Fujisawa T, et al. A case of treatment with voriconazole for chronic progressive pulmonary aspergillosis in a patient receiving tacrolimus for dermatomyositis-associated interstitial lung disease. Respir Med Case Rep. 2015;16:163-5doi: 10.1016/j.rmcr.2015.10.008.
Mochizuki, E., Furuhashi, K., Fujisawa, T., Enomoto, N., Inui, N., Nakamura, Y., Kono, M., Hamada, E., Maekawa, M., & Suda, T. (2015). A case of treatment with voriconazole for chronic progressive pulmonary aspergillosis in a patient receiving tacrolimus for dermatomyositis-associated interstitial lung disease. Respiratory medicine case reports, 16163-5. https://doi.org/10.1016/j.rmcr.2015.10.008
Mochizuki, Eisuke, et al. "A case of treatment with voriconazole for chronic progressive pulmonary aspergillosis in a patient receiving tacrolimus for dermatomyositis-associated interstitial lung disease." Respiratory medicine case reports vol. 16 (2015): 163-5. doi: https://doi.org/10.1016/j.rmcr.2015.10.008
Mochizuki E, Furuhashi K, Fujisawa T, Enomoto N, Inui N, Nakamura Y, Kono M, Hamada E, Maekawa M, Suda T. A case of treatment with voriconazole for chronic progressive pulmonary aspergillosis in a patient receiving tacrolimus for dermatomyositis-associated interstitial lung disease. Respir Med Case Rep. 2015 Nov 03;16:163-5. doi: 10.1016/j.rmcr.2015.10.008. eCollection 2015. PMID: 26744690; PMCID: PMC4681998.
Copy Download .nbib Format: NLM
Phylogenetic identification of n-alkane assimilating Candida yeasts based on nucleotide divergence in the 59 end of LSU rDNA gene.

The Journal of general and applied microbiology

Arie M, Matsuda H, Furuhashi K, Takagi M.
PMID: 12483577
J Gen Appl Microbiol. 2000 Oct;46(5):257-262. doi: 10.2323/jgam.46.257.

Phylogenetic relationships of several species within the n-alkane assimilating Candida yeasts were investigated by using characters from the nucleotide sequence of the variable D1/D2 region at the 5' end of a large-subunit (26S) ribosomal DNA (rDNA) gene. First the...

Cite
Arie M, Matsuda H, Furuhashi K, et al. Phylogenetic identification of n-alkane assimilating Candida yeasts based on nucleotide divergence in the 59 end of LSU rDNA gene. J Gen Appl Microbiol. 2000;46(5):257-262doi: 10.2323/jgam.46.257.
Arie, M., Matsuda, H., Furuhashi, K., & Takagi, M. (2000). Phylogenetic identification of n-alkane assimilating Candida yeasts based on nucleotide divergence in the 59 end of LSU rDNA gene. The Journal of general and applied microbiology, 46(5), 257-262. https://doi.org/10.2323/jgam.46.257
Arie, Mami, et al. "Phylogenetic identification of n-alkane assimilating Candida yeasts based on nucleotide divergence in the 59 end of LSU rDNA gene." The Journal of general and applied microbiology vol. 46,5 (2000): 257-262. doi: https://doi.org/10.2323/jgam.46.257
Arie M, Matsuda H, Furuhashi K, Takagi M. Phylogenetic identification of n-alkane assimilating Candida yeasts based on nucleotide divergence in the 59 end of LSU rDNA gene. J Gen Appl Microbiol. 2000 Oct;46(5):257-262. doi: 10.2323/jgam.46.257. PMID: 12483577.
Copy Download .nbib Format: NLM
Concurrent chemoradiotherapy with low-dose daily cisplatin for high risk uterine cervical cancer: a long-term follow-up study.

Journal of gynecologic oncology

Ushijima K, Fujiyoshi K, Kawano K, Tsuda N, Nishio S, Eto H, Kamura T.
PMID: 23653826
J Gynecol Oncol. 2013 Apr;24(2):108-13. doi: 10.3802/jgo.2013.24.2.108. Epub 2013 Apr 05.

OBJECTIVE: To evaluate the clinical efficacy of concurrent chemoradiotherapy (CCRT) using daily low-dose cisplatin for cervical cancer.METHODS: Fifty-one patients with locally advanced cervical cancer (FIGO stage IB2, bulky IIA, IIB-IVA) who were treated with CCRT as primary therapy at...

Cite
Ushijima K, Fujiyoshi K, Kawano K, et al. Concurrent chemoradiotherapy with low-dose daily cisplatin for high risk uterine cervical cancer: a long-term follow-up study. J Gynecol Oncol. 2013;24(2):108-13doi: 10.3802/jgo.2013.24.2.108.
Ushijima, K., Fujiyoshi, K., Kawano, K., Tsuda, N., Nishio, S., Eto, H., & Kamura, T. (2013). Concurrent chemoradiotherapy with low-dose daily cisplatin for high risk uterine cervical cancer: a long-term follow-up study. Journal of gynecologic oncology, 24(2), 108-13. https://doi.org/10.3802/jgo.2013.24.2.108
Ushijima, Kimio, et al. "Concurrent chemoradiotherapy with low-dose daily cisplatin for high risk uterine cervical cancer: a long-term follow-up study." Journal of gynecologic oncology vol. 24,2 (2013): 108-13. doi: https://doi.org/10.3802/jgo.2013.24.2.108
Ushijima K, Fujiyoshi K, Kawano K, Tsuda N, Nishio S, Eto H, Kamura T. Concurrent chemoradiotherapy with low-dose daily cisplatin for high risk uterine cervical cancer: a long-term follow-up study. J Gynecol Oncol. 2013 Apr;24(2):108-13. doi: 10.3802/jgo.2013.24.2.108. Epub 2013 Apr 05. PMID: 23653826; PMCID: PMC3644685.
Copy Download .nbib Format: NLM
Is human chorionic gonadotropin supplementation beneficial for frozen and thawed embryo transfer in estrogen/progesterone replacement cycles?: A randomized clinical trial.

Reproductive medicine and biology

Shiotani M, Matsumoto Y, Okamoto E, Yamada S, Mizusawa Y, Furuhashi K, Ogata H, Ogata S, Kokeguchi S.
PMID: 29259465
Reprod Med Biol. 2017 Apr 04;16(2):166-169. doi: 10.1002/rmb2.12023. eCollection 2017 Apr.

AIM: Human chorionic gonadotropin (hCG) is used frequently for luteal support in fresh in vitro fertilization cycles as it induces progesterone secretion from the ovaries after oocyte retrieval and modulates the endometrium for implantation in fresh cycles. In contrast,...

Cite
Shiotani M, Matsumoto Y, Okamoto E, et al. Is human chorionic gonadotropin supplementation beneficial for frozen and thawed embryo transfer in estrogen/progesterone replacement cycles?: A randomized clinical trial. Reprod Med Biol. 2017;16(2):166-169doi: 10.1002/rmb2.12023.
Shiotani, M., Matsumoto, Y., Okamoto, E., Yamada, S., Mizusawa, Y., Furuhashi, K., Ogata, H., Ogata, S., & Kokeguchi, S. (2017). Is human chorionic gonadotropin supplementation beneficial for frozen and thawed embryo transfer in estrogen/progesterone replacement cycles?: A randomized clinical trial. Reproductive medicine and biology, 16(2), 166-169. https://doi.org/10.1002/rmb2.12023
Shiotani, Masahide, et al. "Is human chorionic gonadotropin supplementation beneficial for frozen and thawed embryo transfer in estrogen/progesterone replacement cycles?: A randomized clinical trial." Reproductive medicine and biology vol. 16,2 (2017): 166-169. doi: https://doi.org/10.1002/rmb2.12023
Shiotani M, Matsumoto Y, Okamoto E, Yamada S, Mizusawa Y, Furuhashi K, Ogata H, Ogata S, Kokeguchi S. Is human chorionic gonadotropin supplementation beneficial for frozen and thawed embryo transfer in estrogen/progesterone replacement cycles?: A randomized clinical trial. Reprod Med Biol. 2017 Apr 04;16(2):166-169. doi: 10.1002/rmb2.12023. eCollection 2017 Apr. PMID: 29259465; PMCID: PMC5661815.
Copy Download .nbib Format: NLM
Retrospective comparative study of the factors affecting birthweights in frozen-thawed embryo transfer, compared to fresh embryo transfer.

Reproductive medicine and biology

Tsuji Y, Otsuki J, Iwasaki T, Furuhashi K, Matsumoto Y, Kokeguchi S, Shiotani M.
PMID: 29259479
Reprod Med Biol. 2017 Jun 28;16(3):283-289. doi: 10.1002/rmb2.12038. eCollection 2017 Jul.

AIM: Several studies have indicated that the cause of the increased birthweight of frozen-thawed embryos was associated with assisted reproductive technology (ART) procedures, such as cryopreservation. In the present study, the mean birthweight of singletons was compared between the...

Cite
Tsuji Y, Otsuki J, Iwasaki T, et al. Retrospective comparative study of the factors affecting birthweights in frozen-thawed embryo transfer, compared to fresh embryo transfer. Reprod Med Biol. 2017;16(3):283-289doi: 10.1002/rmb2.12038.
Tsuji, Y., Otsuki, J., Iwasaki, T., Furuhashi, K., Matsumoto, Y., Kokeguchi, S., & Shiotani, M. (2017). Retrospective comparative study of the factors affecting birthweights in frozen-thawed embryo transfer, compared to fresh embryo transfer. Reproductive medicine and biology, 16(3), 283-289. https://doi.org/10.1002/rmb2.12038
Tsuji, Yuta, et al. "Retrospective comparative study of the factors affecting birthweights in frozen-thawed embryo transfer, compared to fresh embryo transfer." Reproductive medicine and biology vol. 16,3 (2017): 283-289. doi: https://doi.org/10.1002/rmb2.12038
Tsuji Y, Otsuki J, Iwasaki T, Furuhashi K, Matsumoto Y, Kokeguchi S, Shiotani M. Retrospective comparative study of the factors affecting birthweights in frozen-thawed embryo transfer, compared to fresh embryo transfer. Reprod Med Biol. 2017 Jun 28;16(3):283-289. doi: 10.1002/rmb2.12038. eCollection 2017 Jul. PMID: 29259479; PMCID: PMC5715888.
Copy Download .nbib Format: NLM
Erratum to: Effects on bone metabolism markers and arterial stiffness by switching to rivaroxaban from warfarin in patients with atrial fibrillation.

Heart and vessels

Namba S, Yamaoka-Tojo M, Kakizaki R, Nemoto T, Fujiyoshi K, Hashikata T, Kitasato L, Hashimoto T, Kameda R, Meguro K, Shimohama T, Tojo T, Ako J.
PMID: 28314975
Heart Vessels. 2017 Aug;32(8):983. doi: 10.1007/s00380-017-0966-7.

No abstract available.

Cite
Namba S, Yamaoka-Tojo M, Kakizaki R, et al. Erratum to: Effects on bone metabolism markers and arterial stiffness by switching to rivaroxaban from warfarin in patients with atrial fibrillation. Heart Vessels. 2017;32(8):983doi: 10.1007/s00380-017-0966-7.
Namba, S., Yamaoka-Tojo, M., Kakizaki, R., Nemoto, T., Fujiyoshi, K., Hashikata, T., Kitasato, L., Hashimoto, T., Kameda, R., Meguro, K., Shimohama, T., Tojo, T., & Ako, J. (2017). Erratum to: Effects on bone metabolism markers and arterial stiffness by switching to rivaroxaban from warfarin in patients with atrial fibrillation. Heart and vessels, 32(8), 983. https://doi.org/10.1007/s00380-017-0966-7
Namba, Sayaka, et al. "Erratum to: Effects on bone metabolism markers and arterial stiffness by switching to rivaroxaban from warfarin in patients with atrial fibrillation." Heart and vessels vol. 32,8 (2017): 983. doi: https://doi.org/10.1007/s00380-017-0966-7
Namba S, Yamaoka-Tojo M, Kakizaki R, Nemoto T, Fujiyoshi K, Hashikata T, Kitasato L, Hashimoto T, Kameda R, Meguro K, Shimohama T, Tojo T, Ako J. Erratum to: Effects on bone metabolism markers and arterial stiffness by switching to rivaroxaban from warfarin in patients with atrial fibrillation. Heart Vessels. 2017 Aug;32(8):983. doi: 10.1007/s00380-017-0966-7. PMID: 28314975.
Copy Download .nbib Format: NLM
Incidences and Risk Factors for Postoperative Non-Union after Posterior Lumbar Interbody Fusion with Closed-Box Titanium Spacers.

Asian spine journal

Konomi T, Yasuda A, Fujiyoshi K, Yato Y, Asazuma T.
PMID: 31608613
Asian Spine J. 2020 Feb;14(1):106-112. doi: 10.31616/asj.2019.0024. Epub 2019 Oct 15.

STUDY DESIGN: A retrospective, single-center clinical study with follow-up of more than 24 months.PURPOSE: To evaluate the union rates and relevant risk factors for non-union after posterior lumbar interbody fusion (PLIF) using porous-coated closed-box titanium spacers.OVERVIEW OF LITERATURE: Although...

Cite
Konomi T, Yasuda A, Fujiyoshi K, et al. Incidences and Risk Factors for Postoperative Non-Union after Posterior Lumbar Interbody Fusion with Closed-Box Titanium Spacers. Asian Spine J. 2019;14(1):106-112doi: 10.31616/asj.2019.0024.
Konomi, T., Yasuda, A., Fujiyoshi, K., Yato, Y., & Asazuma, T. (2020). Incidences and Risk Factors for Postoperative Non-Union after Posterior Lumbar Interbody Fusion with Closed-Box Titanium Spacers. Asian spine journal, 14(1), 106-112. https://doi.org/10.31616/asj.2019.0024
Konomi, Tsunehiko, et al. "Incidences and Risk Factors for Postoperative Non-Union after Posterior Lumbar Interbody Fusion with Closed-Box Titanium Spacers." Asian spine journal vol. 14,1 (2020): 106-112. doi: https://doi.org/10.31616/asj.2019.0024
Konomi T, Yasuda A, Fujiyoshi K, Yato Y, Asazuma T. Incidences and Risk Factors for Postoperative Non-Union after Posterior Lumbar Interbody Fusion with Closed-Box Titanium Spacers. Asian Spine J. 2020 Feb;14(1):106-112. doi: 10.31616/asj.2019.0024. Epub 2019 Oct 15. PMID: 31608613; PMCID: PMC7010511.
Copy Download .nbib Format: NLM
Enhanced photovoltaic performances of graphene/Si solar cells by insertion of a MoS₂ thin film.

Nanoscale

Tsuboi Y, Wang F, Kozawa D, Funahashi K, Mouri S, Miyauchi Y, Takenobu T, Matsuda K.
PMID: 26257026
Nanoscale. 2015 Sep 14;7(34):14476-82. doi: 10.1039/c5nr03046c.

Transition-metal dichalcogenides exhibit great potential as active materials in optoelectronic devices because of their characteristic band structure. Here, we demonstrated that the photovoltaic performances of graphene/Si Schottky junction solar cells were significantly improved by inserting a chemical vapor deposition...

Cite
Tsuboi Y, Wang F, Kozawa D, et al. Enhanced photovoltaic performances of graphene/Si solar cells by insertion of a MoS₂ thin film. Nanoscale. 2015;7(34):14476-82doi: 10.1039/c5nr03046c.
Tsuboi, Y., Wang, F., Kozawa, D., Funahashi, K., Mouri, S., Miyauchi, Y., Takenobu, T., & Matsuda, K. (2015). Enhanced photovoltaic performances of graphene/Si solar cells by insertion of a MoS₂ thin film. Nanoscale, 7(34), 14476-82. https://doi.org/10.1039/c5nr03046c
Tsuboi, Yuka, et al. "Enhanced photovoltaic performances of graphene/Si solar cells by insertion of a MoS₂ thin film." Nanoscale vol. 7,34 (2015): 14476-82. doi: https://doi.org/10.1039/c5nr03046c
Tsuboi Y, Wang F, Kozawa D, Funahashi K, Mouri S, Miyauchi Y, Takenobu T, Matsuda K. Enhanced photovoltaic performances of graphene/Si solar cells by insertion of a MoS₂ thin film. Nanoscale. 2015 Sep 14;7(34):14476-82. doi: 10.1039/c5nr03046c. PMID: 26257026.
Copy Download .nbib Format: NLM
Crystal structure and functional analysis of large-terpene synthases belonging to a newly found subclass.

Chemical science

Fujihashi M, Sato T, Tanaka Y, Yamamoto D, Nishi T, Ueda D, Murakami M, Yasuno Y, Sekihara A, Fuku K, Shinada T, Miki K.
PMID: 29780507
Chem Sci. 2018 Mar 16;9(15):3754-3758. doi: 10.1039/c8sc00289d. eCollection 2018 Apr 21.

Thousands of terpenes have been identified to date. However, only two classes of enzymes are known to be involved in their biosynthesis, and each class has characteristic amino-acid motifs. We recently identified a novel large-terpene (C

Cite
Fujihashi M, Sato T, Tanaka Y, et al. Crystal structure and functional analysis of large-terpene synthases belonging to a newly found subclass. Chem Sci. 2018;9(15):3754-3758doi: 10.1039/c8sc00289d.
Fujihashi, M., Sato, T., Tanaka, Y., Yamamoto, D., Nishi, T., Ueda, D., Murakami, M., Yasuno, Y., Sekihara, A., Fuku, K., Shinada, T., & Miki, K. (2018). Crystal structure and functional analysis of large-terpene synthases belonging to a newly found subclass. Chemical science, 9(15), 3754-3758. https://doi.org/10.1039/c8sc00289d
Fujihashi, Masahiro, et al. "Crystal structure and functional analysis of large-terpene synthases belonging to a newly found subclass." Chemical science vol. 9,15 (2018): 3754-3758. doi: https://doi.org/10.1039/c8sc00289d
Fujihashi M, Sato T, Tanaka Y, Yamamoto D, Nishi T, Ueda D, Murakami M, Yasuno Y, Sekihara A, Fuku K, Shinada T, Miki K. Crystal structure and functional analysis of large-terpene synthases belonging to a newly found subclass. Chem Sci. 2018 Mar 16;9(15):3754-3758. doi: 10.1039/c8sc00289d. eCollection 2018 Apr 21. PMID: 29780507; PMCID: PMC5939612.
Copy Download .nbib Format: NLM
Lipoprotein (a) level is associated with plaque vulnerability in patients with coronary artery disease: An optical coherence tomography study.

International journal of cardiology. Heart & vasculature

Muramatsu Y, Minami Y, Kato A, Katsura A, Sato T, Kakizaki R, Nemoto T, Hashimoto T, Fujiyoshi K, Meguro K, Shimohama T, Ako J.
PMID: 31245530
Int J Cardiol Heart Vasc. 2019 Jun 13;24:100382. doi: 10.1016/j.ijcha.2019.100382. eCollection 2019 Sep.

BACKGROUND: High lipoprotein (a) [Lp(a)] levels are an independent factor for worse prognosis in patients with coronary artery disease (CAD). However, the association between serum Lp(a) level and coronary plaque vulnerability remains to be determined.METHODS: A total of 255...

Cite
Muramatsu Y, Minami Y, Kato A, et al. Lipoprotein (a) level is associated with plaque vulnerability in patients with coronary artery disease: An optical coherence tomography study. Int J Cardiol Heart Vasc. 2019;24:100382doi: 10.1016/j.ijcha.2019.100382.
Muramatsu, Y., Minami, Y., Kato, A., Katsura, A., Sato, T., Kakizaki, R., Nemoto, T., Hashimoto, T., Fujiyoshi, K., Meguro, K., Shimohama, T., & Ako, J. (2019). Lipoprotein (a) level is associated with plaque vulnerability in patients with coronary artery disease: An optical coherence tomography study. International journal of cardiology. Heart & vasculature, 24100382. https://doi.org/10.1016/j.ijcha.2019.100382
Muramatsu, Yusuke, et al. "Lipoprotein (a) level is associated with plaque vulnerability in patients with coronary artery disease: An optical coherence tomography study." International journal of cardiology. Heart & vasculature vol. 24 (2019): 100382. doi: https://doi.org/10.1016/j.ijcha.2019.100382
Muramatsu Y, Minami Y, Kato A, Katsura A, Sato T, Kakizaki R, Nemoto T, Hashimoto T, Fujiyoshi K, Meguro K, Shimohama T, Ako J. Lipoprotein (a) level is associated with plaque vulnerability in patients with coronary artery disease: An optical coherence tomography study. Int J Cardiol Heart Vasc. 2019 Jun 13;24:100382. doi: 10.1016/j.ijcha.2019.100382. eCollection 2019 Sep. PMID: 31245530; PMCID: PMC6582072.
Copy Download .nbib Format: NLM
Concurrent nicotine exposure to prenatal alcohol consumption alters the hippocampal and cortical neurotoxicity.

Heliyon

Bhattacharya D, Fujihashi A, Majrashi M, Bloemer J, Bhattacharya S, Buabeid M, Escobar M, Moore T, Suppiramaniam V, Dhanasekaran M.
PMID: 31938742
Heliyon. 2020 Jan 08;6(1):e03045. doi: 10.1016/j.heliyon.2019.e03045. eCollection 2020 Jan.

AIMS: This study investigated the neurotoxic effects of prenatal alcohol and nicotine exposure in the cortex and hippocampus of rodents.MAIN METHODS: Behavioral alterations, electrophysiological changes, and biochemical markers associated with cholinergic neurotransmission, neural oxidative stress, mitochondrial function, and apoptosis...

Cite
Bhattacharya D, Fujihashi A, Majrashi M, et al. Concurrent nicotine exposure to prenatal alcohol consumption alters the hippocampal and cortical neurotoxicity. Heliyon. 2020;6(1):e03045doi: 10.1016/j.heliyon.2019.e03045.
Bhattacharya, D., Fujihashi, A., Majrashi, M., Bloemer, J., Bhattacharya, S., Buabeid, M., Escobar, M., Moore, T., Suppiramaniam, V., & Dhanasekaran, M. (2020). Concurrent nicotine exposure to prenatal alcohol consumption alters the hippocampal and cortical neurotoxicity. Heliyon, 6(1), e03045. https://doi.org/10.1016/j.heliyon.2019.e03045
Bhattacharya, Dwipayan, et al. "Concurrent nicotine exposure to prenatal alcohol consumption alters the hippocampal and cortical neurotoxicity." Heliyon vol. 6,1 (2020): e03045. doi: https://doi.org/10.1016/j.heliyon.2019.e03045
Bhattacharya D, Fujihashi A, Majrashi M, Bloemer J, Bhattacharya S, Buabeid M, Escobar M, Moore T, Suppiramaniam V, Dhanasekaran M. Concurrent nicotine exposure to prenatal alcohol consumption alters the hippocampal and cortical neurotoxicity. Heliyon. 2020 Jan 08;6(1):e03045. doi: 10.1016/j.heliyon.2019.e03045. eCollection 2020 Jan. PMID: 31938742; PMCID: PMC6953639.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 153 entries